Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides
- 26 October 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (24) , 6001-6006
- https://doi.org/10.1016/j.bmcl.2004.09.085
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Antiviral Sulfonamide DerivativesMini-Reviews in Medicinal Chemistry, 2004
- Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site RecognitionJournal of Medicinal Chemistry, 2003
- Anticancer and Antiviral SulfonamidesCurrent Medicinal Chemistry, 2003
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Advances in the field of COX-2 inhibitionExpert Opinion on Therapeutic Patents, 2002
- Bacterial protease inhibitorsMedicinal Research Reviews, 2002
- Novel sulphonamide derivatives for the treatment of cancerExpert Opinion on Therapeutic Patents, 2000
- Carbonic anhydrase inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000
- Ein Beitrag zur Chemotherapie der bakteriellen InfektionenDeutsche Medizinische Wochenschrift (1946), 1935